Insider · CIK 0001646976

Adda Nathalie

Reports to the SEC for 1 company · WATERTOWN, MA

sec.gov

Transactions

Companies

Filings

CIK

0001646976

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2022-04-04	ENTAENANTA PHARMACEUTICALS INC · Stock Option (Right to Buy)M Exercise/Conversion	Sr. VP & Chief Medical Officer	MExercise/Conversion	−16.9K sh	—	—	13,125
2022-04-04	ENTAENANTA PHARMACEUTICALS INCM Exercise/Conversion	Sr. VP & Chief Medical Officer	MExercise/Conversion	+6,285 sh	$48.52	+$305K	41,267
2022-04-04	ENTAENANTA PHARMACEUTICALS INCS Sale	Sr. VP & Chief Medical Officer	SSale	−18.1K sh	$71.71	−$1.3M	47,191
2022-04-04	ENTAENANTA PHARMACEUTICALS INCM Exercise/Conversion	Sr. VP & Chief Medical Officer	MExercise/Conversion	+16.9K sh	$63.35	+$1.07M	67,767
2022-04-04	ENTAENANTA PHARMACEUTICALS INCS Sale	Sr. VP & Chief Medical Officer	SSale	−9,009 sh	$73.42	−$661K	34,982
2022-04-04	ENTAENANTA PHARMACEUTICALS INC · Stock Option (Right to Buy)M Exercise/Conversion	Sr. VP & Chief Medical Officer	MExercise/Conversion	−6,285 sh	—	—	0
2022-04-04	ENTAENANTA PHARMACEUTICALS INC · Stock Option (Right to Buy)M Exercise/Conversion	Sr. VP & Chief Medical Officer	MExercise/Conversion	−9,625 sh	—	—	21,175
2022-04-04	ENTAENANTA PHARMACEUTICALS INCM Exercise/Conversion	Sr. VP & Chief Medical Officer	MExercise/Conversion	+9,625 sh	$43.57	+$419K	50,892
2022-04-04	ENTAENANTA PHARMACEUTICALS INCS Sale	Sr. VP & Chief Medical Officer	SSale	−3,200 sh	$72.65	−$232K	43,991
2022-04-04	ENTAENANTA PHARMACEUTICALS INCS Sale	Sr. VP & Chief Medical Officer	SSale	−2,500 sh	$70.56	−$176K	65,267
2022-04-01	ENTAENANTA PHARMACEUTICALS INC · Stock Option (Right to Buy)M Exercise/Conversion	Sr. VP & Chief Medical Officer	MExercise/Conversion	−2,895 sh	—	—	6,285
2022-04-01	ENTAENANTA PHARMACEUTICALS INCS Sale	Sr. VP & Chief Medical Officer	SSale	−42.3K sh	$71.32	−$3.01M	34,982
2022-04-01	ENTAENANTA PHARMACEUTICALS INCM Exercise/Conversion	Sr. VP & Chief Medical Officer	MExercise/Conversion	+2,895 sh	$48.52	+$140K	85,541
2022-04-01	ENTAENANTA PHARMACEUTICALS INCS Sale	Sr. VP & Chief Medical Officer	SSale	−8,299 sh	$70.75	−$587K	77,242
2022-04-01	ENTAENANTA PHARMACEUTICALS INCM Exercise/Conversion	Sr. VP & Chief Medical Officer	MExercise/Conversion	+31.7K sh	$30.00	+$950K	82,646
2022-04-01	ENTAENANTA PHARMACEUTICALS INC · Stock Option (Right to Buy)M Exercise/Conversion	Sr. VP & Chief Medical Officer	MExercise/Conversion	−16K sh	—	—	0
2022-04-01	ENTAENANTA PHARMACEUTICALS INC · Stock Option (Right to Buy)M Exercise/Conversion	Sr. VP & Chief Medical Officer	MExercise/Conversion	−31.7K sh	—	—	0
2022-04-01	ENTAENANTA PHARMACEUTICALS INCM Exercise/Conversion	Sr. VP & Chief Medical Officer	MExercise/Conversion	+16K sh	$31.42	+$503K	50,982
2022-03-02	ENTAENANTA PHARMACEUTICALS INC · Stock Option (Right to Buy)M Exercise/Conversion	Sr. VP & Chief Medical Officer	MExercise/Conversion	−12.5K sh	—	—	0
2022-03-02	ENTAENANTA PHARMACEUTICALS INCM Exercise/Conversion	Sr. VP & Chief Medical Officer	MExercise/Conversion	+12.5K sh	$43.46	+$542K	47,463
2022-03-02	ENTAENANTA PHARMACEUTICALS INCS Sale	Sr. VP & Chief Medical Officer	SSale	−12.5K sh	$70.07	−$875K	34,982
2022-03-01	ENTAENANTA PHARMACEUTICALS INCS Sale	Sr. VP & Chief Medical Officer	SSale	−100 sh	$71.06	−$7,106	34,982
2022-03-01	ENTAENANTA PHARMACEUTICALS INC · Stock Option (Right to Buy)M Exercise/Conversion	Sr. VP & Chief Medical Officer	MExercise/Conversion	−24.3K sh	—	—	12,481
2022-03-01	ENTAENANTA PHARMACEUTICALS INCM Exercise/Conversion	Sr. VP & Chief Medical Officer	MExercise/Conversion	+24.3K sh	$43.46	+$1.06M	59,321
2022-03-01	ENTAENANTA PHARMACEUTICALS INCS Sale	Sr. VP & Chief Medical Officer	SSale	−24.2K sh	$70.26	−$1.7M	35,082
2022-02-14	ENTAENANTA PHARMACEUTICALS INCA Award	Sr. VP & Chief Medical Officer	AAward	+2,419 sh	—	—	35,936
2022-02-14	ENTAENANTA PHARMACEUTICALS INCF Tax Payment	Sr. VP & Chief Medical Officer	FTax Payment	−954 sh	$62.49	−$59.6K	34,982
2022-02-14	ENTAENANTA PHARMACEUTICALS INCA Award	Sr. VP & Chief Medical Officer	AAward	+615 sh	—	—	33,517
2022-01-11	ENTAENANTA PHARMACEUTICALS INC · Stock Option (Right to Buy)M Exercise/Conversion	Sr. VP & Chief Medical Officer	MExercise/Conversion	−9,200 sh	—	—	36,820
2022-01-11	ENTAENANTA PHARMACEUTICALS INC · Stock Option (Right to Buy)M Exercise/Conversion	Sr. VP & Chief Medical Officer	MExercise/Conversion	−3,336 sh	—	—	31,664
2022-01-11	ENTAENANTA PHARMACEUTICALS INCM Exercise/Conversion	Sr. VP & Chief Medical Officer	MExercise/Conversion	+3,336 sh	$30.00	+$100K	45,438
2022-01-11	ENTAENANTA PHARMACEUTICALS INCM Exercise/Conversion	Sr. VP & Chief Medical Officer	MExercise/Conversion	+9,200 sh	$43.46	+$400K	42,102
2022-01-11	ENTAENANTA PHARMACEUTICALS INCS Sale	Sr. VP & Chief Medical Officer	SSale	−12.5K sh	$70.13	−$879K	32,902
2021-12-01	ENTAENANTA PHARMACEUTICALS INC · Stock Option (Right to Buy)M Exercise/Conversion	Sr. VP & Chief Medical Officer	MExercise/Conversion	−4,773 sh	—	—	9,180
2021-12-01	ENTAENANTA PHARMACEUTICALS INC · Stock Option (Right to Buy)M Exercise/Conversion	Sr. VP & Chief Medical Officer	MExercise/Conversion	−8,750 sh	—	—	46,020
2021-12-01	ENTAENANTA PHARMACEUTICALS INCS Sale	Sr. VP & Chief Medical Officer	SSale	−201 sh	$90.17	−$18.1K	32,902
2021-12-01	ENTAENANTA PHARMACEUTICALS INCS Sale	Sr. VP & Chief Medical Officer	SSale	−899 sh	$89.33	−$80.3K	33,103
2021-12-01	ENTAENANTA PHARMACEUTICALS INCS Sale	Sr. VP & Chief Medical Officer	SSale	−900 sh	$88.31	−$79.5K	34,002
2021-12-01	ENTAENANTA PHARMACEUTICALS INCS Sale	Sr. VP & Chief Medical Officer	SSale	−1,500 sh	$87.60	−$131K	34,902
2021-12-01	ENTAENANTA PHARMACEUTICALS INCS Sale	Sr. VP & Chief Medical Officer	SSale	−2,700 sh	$86.45	−$233K	36,402
2021-12-01	ENTAENANTA PHARMACEUTICALS INCS Sale	Sr. VP & Chief Medical Officer	SSale	−5,736 sh	$85.49	−$490K	39,102
2021-12-01	ENTAENANTA PHARMACEUTICALS INCS Sale	Sr. VP & Chief Medical Officer	SSale	−1,587 sh	$84.81	−$135K	44,838
2021-12-01	ENTAENANTA PHARMACEUTICALS INCM Exercise/Conversion	Sr. VP & Chief Medical Officer	MExercise/Conversion	+4,773 sh	$48.52	+$232K	46,425
2021-12-01	ENTAENANTA PHARMACEUTICALS INCM Exercise/Conversion	Sr. VP & Chief Medical Officer	MExercise/Conversion	+8,750 sh	$43.46	+$380K	41,652
2021-12-01	ENTAENANTA PHARMACEUTICALS INCF Tax Payment	Sr. VP & Chief Medical Officer	FTax Payment	−842 sh	$87.68	−$73.8K	32,902
2021-11-19	ENTAENANTA PHARMACEUTICALS INCA Award	Sr. VP & Chief Medical Officer	AAward	+6,800 sh	—	—	33,744
2021-11-19	ENTAENANTA PHARMACEUTICALS INC · Stock Option (right to buy)A Award	Sr. VP & Chief Medical Officer	AAward	+28.4K sh	—	—	28,400
2021-11-01	ENTAENANTA PHARMACEUTICALS INCS Sale	Sr. VP & Chief Medical Officer	SSale	−100 sh	$86.21	−$8,621	26,944
2021-11-01	ENTAENANTA PHARMACEUTICALS INCS Sale	Sr. VP & Chief Medical Officer	SSale	−7,495 sh	$85.02	−$637K	27,044
2021-11-01	ENTAENANTA PHARMACEUTICALS INCS Sale	Sr. VP & Chief Medical Officer	SSale	−1,952 sh	$84.31	−$165K	34,539

Recent filings

Accepted (ET)
Apr 54
Adda Nathalie0001062993-22-009836
SEC(opens sec.gov)
Mar 34
Adda Nathalie0001062993-22-006708
SEC(opens sec.gov)

Companies

ENANTA PHARMACEUTICALS INCSr. VP & Chief Medical OfficerENTA

Address

C/O ENANTA PHARMACEUTICALS, INC. 500 ARSENAL STREET

WATERTOWN, MA, 02472